Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 4,858 shares at $20.74 ($101K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Seasonal sale ($101k) by Chief Commercial Officer — this insider has traded ACOR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.74 | 2,429 | $50K | 50.0% |
| 2 | $20.74 | 2,429 | $50K | 50.0% |
| Total | $20.74 avg | 4,858 | $101K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |